Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study.
Iglicki M, Busch C, Lanzetta P, Sarao V, Veritti D, Rassu N, Lupidi M, Cebeci Z, Fraser-Bell S, Bernal-Morales C, Sala-Puigdollers A, Zarranz-Ventura J, Gallego-Pinazo R, Maiti A, D'Amico Ricci G, Udaondo P, Loewenstein A, Chhablani J, Zur D. Iglicki M, et al. Among authors: d amico ricci g, zur d. Eye (Lond). 2023 Feb;37(2):280-284. doi: 10.1038/s41433-022-01931-9. Epub 2022 Jan 18. Eye (Lond). 2023. PMID: 35043004 Free PMC article.
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.
Busch C, Zur D, Fraser-Bell S, Laíns I, Santos AR, Lupidi M, Cagini C, Gabrielle PH, Couturier A, Mané-Tauty V, Giancipoli E, Ricci GD, Cebeci Z, Rodríguez-Valdés PJ, Chaikitmongkol V, Amphornphruet A, Hindi I, Agrawal K, Chhablani J, Loewenstein A, Iglicki M, Rehak M; International Retina Group. Busch C, et al. Among authors: zur d. Acta Diabetol. 2018 Aug;55(8):789-796. doi: 10.1007/s00592-018-1151-x. Epub 2018 May 5. Acta Diabetol. 2018. PMID: 29730822
One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
Singh SR, Fung AT, Fraser-Bell S, Lupidi M, Mohan S, Gabrielle PH, Zur D, Iglicki M, M López-Corell P, Gallego-Pinazo R, Farinha C, Lima LH, Mansour AM, Casella AM, Wu L, Silva R, Uwaydat SH, Govindahari V, Arevalo JF, Chhablani J. Singh SR, et al. Among authors: zur d. Br J Ophthalmol. 2020 May;104(5):678-683. doi: 10.1136/bjophthalmol-2019-314542. Epub 2019 Aug 10. Br J Ophthalmol. 2020. PMID: 31401554
Tips to optimize digital education in ophthalmology: Results from ESASO survey.
Ferrara M, Romano V, Iovino C, Kadhim MR, van Dijk EH, Boon CJ, Grassi P, Demirel S, Cartes C, Romano MR; e-LOS Study Group. Ferrara M, et al. Eur J Ophthalmol. 2022 Apr 13;33(2):11206721221093187. doi: 10.1177/11206721221093187. Online ahead of print. Eur J Ophthalmol. 2022. PMID: 35414278 Free PMC article.
One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysis.
Arora S, Maltsev DS, Singh Randhir S, Sahoo NK, Jhingan M, Parmeshwarappa D, Arora T, Kulikov A, Iovino C, Zur D, Fainberg G, Ibrahim MN, Tatti F, Gujar R, Venkatesh R, Reddy N, Snehith R, Peiretti E, Lupidi M, Chhablani J. Arora S, et al. Among authors: zur d. Eur J Ophthalmol. 2022 Jul;32(4):2319-2327. doi: 10.1177/11206721211055018. Epub 2021 Nov 6. Eur J Ophthalmol. 2022. PMID: 34747194
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity.
Busch C, Okada M, Zur D, Fraser-Bell S, Rodríguez-Valdés PJ, Cebeci Z, Lupidi M, Fung AT, Gabrielle PH, Giancipoli E, Chaikitmongkol V, Laíns I, Santos AR, Kunavisarut P, Sala-Puigdollers A, Chhablani J, Ozimek M, Hilely A, Degenhardt V, Loewenstein A, Iglicki M, Rehak M; International Retina Group. Busch C, et al. Among authors: zur d. Acta Ophthalmol. 2020 Nov;98(7):e801-e806. doi: 10.1111/aos.14390. Epub 2020 Mar 1. Acta Ophthalmol. 2020. PMID: 32115886 Free article.
138 results